BIO-

Bio-Rad Laboratories Inc

NYSE: BIO-B · HEALTHCARE · MEDICAL DEVICES

$255.54

+0.00% today

Updated 2026-06-05

Market cap

$8.14B

P/E ratio

50.52

P/S ratio

3.14x

EPS (TTM)

$6.02

Dividend yield

—

52W range

$245 – $321

Volume

0.0M

Market cap

$8.14B

P/E ratio

50.52

P/S ratio

3.14x

EPS (TTM)

$6.02

Dividend yield

—

52W range

$245 – $321

Volume

0.0M

WallStSmart proprietary scores

out of 100

Grade: D

Sell

Investment rating

2.7

Growth

8.5

Quality

4.5

Profitability

3.0

Valuation

3/9

Piotroski F-Score

Weak

3.1

Altman Z-Score

Safe zone

—

Industry rank

—

View all highly rated stocks (75+) →198 stocks currently score above 75

Price targets

Analyst target

—

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

Price chart

Stock snapshot

Strengths

+ Altman Z 3.11 — safe zone

+ Free cash flow $78.10M — positive

+ Debt/equity 0.20x — low leverage

Risks

- Piotroski 3/9 — weak financial health

- P/E 50.52x — expensive valuation

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$2.80B	$2.67B	$2.57B	$2.58B	$2.59B
Net income	$-3.63B	$-637.32M	$-1.84B	$759.90M	$-527.10M
EPS	—	—	—	—	$6.02
Free cash flow	$80.29M	$218.26M	$266.20M	$374.60M	$78.10M
Profit margin	-129.45%	-23.86%	-71.86%	29.42%	6.52%

Recent insider activity

Date	Insider	Type	Shares	Price
2026-05-11	ENGELHARDT, EVA ANETTE	Sale	550	$246.54
2026-04-24	LAKKARAJU, ROOP KALYAN	Sale	1,078	—
2026-04-24	LAKKARAJU, ROOP KALYAN	Buy	1,078	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
BIO-B	$8.14B	35	2.7	4.5	3.0	8.5	—	Hold
LLY	$948.95B	78	10.0	10.0	5.0	6.0	—	Strong Buy
JNJ	$536.54B	59	4.7	9.0	3.3	6.0	-71.41%	Buy
ABBV	$380.57B	63	4.0	8.0	4.0	5.0	-55.64%	Buy
UNH	$343.21B	54	5.3	5.5	4.7	5.5	-26.61%	Buy
MRK	$285.64B	50	3.3	8.0	2.7	5.0	-49.34%	Hold

Smart narrative

Bio-Rad Laboratories Inc trades at $255.54. representing a P/E of 50.52x trailing earnings. Our Smart Value Score of 35/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of 3.11, it sits in the safe zone. TTM revenue stands at $2.59B. with profit margins at 6.52%.

Frequently asked questions

What is Bio-Rad Laboratories Inc's stock price?

Bio-Rad Laboratories Inc (BIO-B) trades at $255.54, on a P/E of 50.5x and a P/S of 3.1x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.

Is Bio-Rad Laboratories Inc overvalued?

Bio-Rad Laboratories Inc carries a Smart Value Score of 35/100 (Grade D), which we rate Sell. That score blends growth, quality, and valuation into one read.

What is Bio-Rad Laboratories Inc's revenue?

Bio-Rad Laboratories Inc's trailing twelve-month revenue is $2.59B. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.

Altman Z-Score?

Bio-Rad Laboratories Inc's Altman Z-Score is 3.11, which places it in the safe zone. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.

Company info

SectorHEALTHCARE

IndustryMEDICAL DEVICES

CountryUSA

ExchangeNYSE

CurrencyUSD

www.bio-rad.com

Quick metrics

P/S ratio3.14x

ROE2.46%

Beta1.06

50D MA$279.03

200D MA$286.58

Shares out0.01B

Float0.02B

Short ratio—

Avg volume0.0M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

BIO-B vs LLY →BIO-B vs JNJ →BIO-B vs ABBV →Stock screener →